Asthma is one of the most prevalent respiratory diseases worldwide, and prevalence is projected to increase over the coming decades, particularly in the US as the population
continues to grow. This chronic disease is associated with increased morbidity, detrimental impacts on quality of life, and high health care costs especially in the severe
asthma population. Asthma management utilizes a stepwise approach to control symptoms while minimizing risks.
Download this white paper, which looks at novel biologics in development for the treatment of uncontrolled, eosinophilic asthma and whether they can fulfill the promise of truly targeted therapies for one of the most prevalent respiratory diseases worldwide.
Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: